Analog Devices Inc

ADI

Equity

ISIN null / Valor 907697

NASDAQ (2026-01-23)

USD 305.60-0.95%

Analog Devices Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Analog Devices Inc. is a multinational semiconductor company headquartered in Wilmington, Massachusetts, that designs, manufactures and sells analog, mixed-signal and digital signal-processing integrated circuits and subsystems. Its product portfolio centers on data converters (ADCs and DACs), precision and operational amplifiers, sensor interfaces and MEMS sensors, power-management ICs, and RF front‑end components, together with associated software and evaluation tools. These components are used to convert, condition and process real-world signals for customers across industrial automation and instrumentation, communications infrastructure, automotive (including ADAS and electrification), healthcare imaging and monitoring, aerospace and defense, and selected consumer applications. Analog Devices is publicly traded (NASDAQ: ADI) and operates globally through a mix of internal manufacturing, design centers and distribution partners.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

33.8%1Y

80.1%3Y

96.4%5Y

Performance

39.2%1Y

32.7%3Y

32.6%5Y

Volatility

149638 M

Market cap (USD)

2,907,157

Daily traded volume (Shares)

214.625 / 211.08

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

3.00

Innovation:

3.00

Society:

3.00

Nature:

1.00

Tej Ram Kumpakha

Switzerland, 24 Mar 2022

the company is slightly undervalued, they are successful to achieve positive financial results and impressive return on assets; the dividend yield is growing at an average of around 10% annually.

EQUITIES OF THE SAME SECTOR

Regeneron Pharmaceuticals Inc